ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

9.81

+0.05 (0.51%)

At close: Jun 15, 2026, 4:00 PM EDT

9.90

+0.09 (0.92%)

Pre-market: Jun 16, 2026, 4:40 AM EDT

ARS Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	98.99	84.28	89.15	0.03	1.32	5.51
Revenue Growth (YoY)	1.92%	-5.46%	297063.33%	-97.72%	-76.10%	-
Cost of Revenue	25.62	20.42	0.98	-	-	-
Gross Profit	73.37	63.86	88.17	0.03	1.32	5.51
Selling, General & Admin	261.22	230.12	71.68	47.28	18.46	4.69
Research & Development	14.57	13.18	19.58	20.27	18.38	20.27
Total Operating Expenses	275.79	243.3	91.26	67.55	36.83	24.96
Operating Income	-202.42	-179.45	-3.08	-67.52	-35.52	-19.45
Interest Income	1.97	10.67	11.37	-	-	-
Interest Expense	-2.44	-2.6	-	-	-	-
Other Non-Operating Income (Expense)	-	-	-	-	-0.14	-
Total Non-Operating Income (Expense)	-0.47	8.07	11.37	-	-0.14	-
Pretax Income	-202.89	-171.38	8.29	-67.52	-35.66	-19.45
Provision for Income Taxes	-	-0.08	0.29	-	-	-
Net Income	-197.98	-171.3	8	-54.37	-34.68	-20.24
Net Income to Common	-197.98	-171.3	8	-54.37	-34.68	-20.24
Shares Outstanding (Basic)	99	99	97	95	40	29
Shares Outstanding (Diluted)	99	99	102	95	40	29
Shares Change (YoY)	-3.81%	-3.74%	7.54%	138.30%	38.39%	893.01%
EPS (Basic)	-2.01	-1.74	0.08	-0.57	-0.87	-0.70
EPS (Diluted)	-2.01	-1.74	0.08	-0.57	-0.87	-0.70
Free Cash Flow	-175.34	-171.21	12.99	-59.44	-40.28	-17.62
Free Cash Flow Per Share	-1.77	-1.74	0.13	-0.62	-1.01	-0.61
Gross Margin	74.12%	75.77%	98.90%	100.00%	100.00%	100.00%
Operating Margin	-204.49%	-212.92%	-3.46%	-225067.00%	-2698.78%	-353.32%
Profit Margin	-200.00%	-203.25%	8.97%	-181217.00%	-2635.41%	-367.65%
FCF Margin	-177.13%	-203.14%	14.57%	-198137.00%	-3060.56%	-319.94%
EBITDA	-200.93	-178.08	-3	-67.45	-35.48	-19.24
EBITDA Margin	-202.99%	-211.30%	-3.37%	-224823.00%	-2696.20%	-349.45%
EBIT	-202.42	-179.45	-3.08	-67.52	-35.52	-19.45
EBIT Margin	-204.49%	-212.92%	-3.46%	-225067.00%	-2698.78%	-353.32%
Effective Tax Rate	-	0.05%	3.48%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q